RE: Benefit of NASDAQ Listing14 Apr 2020 20:07
Summit Appoints Robert W. Duggan as Chief Executive Officer https://t.co/Z0G1IViCmE
"Oxford, UK, and Cambridge, MA, US, 14 April 2020 – Summit Therapeutics plc (NASDAQ: SMMT) today announces that Mr Robert (Bob) Duggan has been appointed Chief Executive Officer (‘CEO’) of Summit Therapeutics, effective immediately. Mr Duggan will retain his role as Chairman of the Board. Mr Duggan will serve as CEO without compensation as he is Summit’s leading shareholder.
Mr Glyn Edwards has tendered his resignation, which will be effective immediately."